Gene · 773
Papers4,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Realizing Single Chip White Light InGaN LED via Dual-Wavelength Multiple Quantum Wells. | Materials (Basel) | 2022 | 35683296 | PubTator, text mining | PubMed |
| Molecularly cleavable bioinks facilitate high-performance digital light processing-based bioprinting of functional volumetric soft tissues. | Nat Commun | 2022 | 35680907 | PubTator, text mining | PubMed |
| Case Report: A Novel CACNA1A Mutation Caused Flunarizine-Responsive Type 2 Episodic Ataxia and Hemiplegic Migraine With Abnormal MRI of Cerebral White Matter. | Front Neurol | 2022 | 35677330 | PubTator, text mining | PubMed |
| Acetazolamide: Old drug, new evidence? | Epilepsia Open | 2022 | 35673961 | PubTator, text mining | PubMed |
| Rare CACNA1H and RELN variants interact through mTORC1 pathway in oligogenic autism spectrum disorder. | Transl Psychiatry | 2022 | 35668055 | PubTator, text mining | PubMed |
| Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study. | BMC Med | 2022 | 35658861 | PubTator, text mining | PubMed |
| Complex effects on CaV2.1 channel gating caused by a CACNA1A variant associated with a severe neurodevelopmental disorder. | Sci Rep | 2022 | 35655070 | PubTator, text mining | PubMed |
| Towards bridging the translational gap by improved modeling of human nociception in health and disease. | Pflugers Arch | 2022 | 35655042 | PubTator, text mining | PubMed |
| Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer. | Clin Cancer Res | 2022 | 35653140 | PubTator, text mining | PubMed |
| Is Arsenic Exposure a Risk Factor for Metabolic Syndrome? A Review of the Potential Mechanisms. | Front Endocrinol (Lausanne) | 2022 | 35651975 | PubTator, text mining | PubMed |
| Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35650269 | PubTator, text mining | PubMed |
| Commentary: The genetics of pseudoexfoliation syndrome/glaucoma. | Indian J Ophthalmol | 2022 | 35647974 | PubTator, text mining | PubMed |
| High-Throughput Evaluation of Emission and Structure in Reduced-Dimensional Perovskites. | ACS Cent Sci | 2022 | 35647281 | PubTator, text mining | PubMed |
| Structural Abnormalities of the Optic Nerve and Retina in Huntington's Disease Pre-Clinical and Clinical Settings. | Int J Mol Sci | 2022 | 35628260 | PubTator, text mining | PubMed |
| The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies. | Genes (Basel) | 2022 | 35627257 | PubTator, text mining | PubMed |
| Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects. | Biomedicines | 2022 | 35625877 | PubTator, text mining | PubMed |
| Pathophysiological Responses to Conotoxin Modulation of Voltage-Gated Ion Currents. | Mar Drugs | 2022 | 35621933 | PubTator, text mining | PubMed |
| Case Report: Migraine-Induced Dystonia of the Lower Extremities. | Front Neurol | 2022 | 35614918 | PubTator, text mining | PubMed |
Effectiveness and cost-effectiveness of dynamic bracing versus standard care alone in patients suffering from osteoporotic vertebral compression fractures: protocol for a multicentre, two-armed, parallel-group randomised controlled trial with 12 months of follow-up. | BMJ Open | 2022 | 35613823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/773/papers?page=43